Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Eledon Pharmaceuticals Inc. buy Maxi_Scalibusa

Eledon Pharmaceuticals Inc.
Start price
€13.36
23.01.21 / 50%
Target price
€100.00
23.01.22
Performance (%)
-77.10%
End price
€3.06
24.01.22
Summary
This prediction ended on 24.01.22 with a price of €3.06. The BUY prediction by Maxi_Scalibusa for Eledon Pharmaceuticals Inc. performed very badly with a performance of -77.10%. Maxi_Scalibusa has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Eledon Pharmaceuticals Inc. 6.849% 6.849% 43.119% 186.239%
iShares Core DAX® 0.437% 5.897% 8.047% 65.579%
iShares Nasdaq 100 1.057% 0.920% 28.466% 90.185%
iShares Nikkei 225® 1.769% 1.228% 47.574% 84.991%
iShares S&P 500 0.368% 1.920% 23.200% 70.760%

According to Maxi_Scalibusa what are the pros and cons of Eledon Pharmaceuticals Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by Maxi_Scalibusa for this prediction

In the thread Novus Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -77.10%
Target price 100.000
Change
Ends at

Buy mit Kursziel 100,0

Maxi_Scalibusa 
0
Report Share
23.01.21
In the thread Trading Novus Therapeutics Inc.
Prediction Buy
Perf. (%) -77.10%
Target price 100.000
Change
Ends at 23.01.22

Die von Maxi_Scalibusa gewählte maximale Laufzeit wurde überschritten

Maxi_Scalibusa 
0
Report Share
24.01.22